Asensus Surgical Inc (ASXC)

Currency in USD
0.348
0.000(0.00%)
Real-time Data·
Showing Asensus Surgical historical data. For real-time data please try another search
Fair Value
Day's Range
0.3460.350
52 wk Range
0.1690.350
Key Statistics
Prev. Close
0.348
Open
0.346
Day's Range
0.346-0.35
52 wk Range
0.169-0.349
Volume
-
Average Volume (3m)
3.08M
1-Year Change
9.06%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ASXC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Asensus Surgical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Asensus Surgical Inc Company Profile

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company’s products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina. As of August 22, 2024, Asensus Surgical, Inc. operates as a subsidiary of KARL STORZ Endoscopy-America, Inc.

Compare ASXC to Peers and Sector

Metrics to compare
ASXC
Peers
Sector
Relationship
P/E Ratio
0.0x−2.6x−0.5x
PEG Ratio
0.000.080.00
Price/Book
0.0x2.7x2.6x
Price / LTM Sales
0.0x2.2x3.3x
Upside (Analyst Target)
0.0%44.1%43.5%
Fair Value Upside
Unlock7.8%6.3%Unlock

Earnings

Latest Release
Nov 12, 2024
EPS / Forecast
-- / -0.04
Revenue / Forecast
-- / 5.80M
EPS Revisions
Last 90 days

ASXC Income Statement

People Also Watch

10.255
ACHR
-1.68%
47.34
NVO
-3.02%
765.98
LLY
-0.39%
12.29
RIVN
-1.01%
692.19
ASML
-1.03%
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.